|
|
| Quarterly Results |
|
| Hester Biosciences Ltd | | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Bhupendra V Gandhi | | Home : Indian Private | Book Value: 351.3466653 | | BSE Code : 524669 | Market Cap: 1437.49 | | NSE Code : HESTERBIO | P / E : 55.31 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 65.51 | 66.43 | 80.35 | 60.70 | | Other Income | 0.98 | 1.22 | 0.86 | 0.95 | | Total Income | 66.49 | 67.65 | 81.20 | 61.65 | | Total Expenditure | 53.94 | 54.44 | 68.98 | 49.78 | | Operating Profit | 12.55 | 13.21 | 12.22 | 11.87 | | Interest | 1.37 | 1.48 | 0.94 | 0.35 | | Gross Profit | 11.18 | 11.74 | 11.28 | 11.52 | | Depreciation | 2.57 | 2.58 | 2.55 | 2.62 | | Tax | 1.51 | 2.48 | 2.37 | 2.29 | | Deferred Tax | 0.63 | -0.11 | -0.10 | 0.35 | | Reported Profit After Tax | 6.48 | 6.78 | 6.47 | 6.26 |
|
|
|
|
|